Breast Cancer

Top Story

MEN1 associated with early-onset breast cancer risk in women

MEN1 associated with early-onset breast cancer risk in women
March 24, 2017

Women with multiple endocrine neoplasia type 1 are at greater risk for developing early-onset breast cancer compared with women without the disease, according to findings from a cross-sectional study.

Rachel S. van Leeuwaarde, MD, of the department of endocrine oncology at University Medical Center Utrecht, the Netherlands, and colleagues analyzed data from 138 women with confirmed multiple endocrine neoplasia type 1 (MEN1) or a MEN1 mutation from the Dutch MEN1 cohort, a longitudinal database that includes at least 90% of all Dutch MEN1 patients aged at least 16 years. Women completed either a written or online questionnaire between April 2015 and October 2016 regarding breast cancer-related endocrine risk factors, cancer family history and other known risk factors for breast cancer. Researchers compared the age at breast cancer diagnosis among the MEN1 cohort with the female relatives without MEN1, as well as age of breast cancer onset in the general Dutch population using data from the Netherlands Cancer Registry.

In the Journals Plus

Neurofeedback may ease pain of chemotherapy-induced neuropathy

March 23, 2017
Functional brain training, known as neurofeedback, effectively reduced symptoms associated with chemotherapy-induced peripheral neuropathy, according to a randomized…
In the Journals Plus

Cancer survivors more likely to have preterm birth, cesarean delivery

March 23, 2017
Adult survivors of adolescent and young adult cancers were more likely to experience preterm birth, low birth weight and cesarean delivery compared with births by women…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News Coverage

VIDEO: Additional research necessary to define role of PARP inhibitors for BRCA–mutated breast cancer

January 9, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

In the Journals PlusAbstract Only

Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

March 28, 2017
AUTHORS:
Hart CD, et al.

In the Journals Plus

MEN1 associated with early-onset breast cancer risk in women

March 24, 2017
Women with multiple endocrine neoplasia type 1 are at greater risk for developing early-onset breast cancer compared with women without the disease…

In the Journals Plus

Neurofeedback may ease pain of chemotherapy-induced neuropathy

March 23, 2017
Functional brain training, known as neurofeedback, effectively reduced symptoms associated with chemotherapy-induced peripheral neuropathy, according…

In the Journals Plus

Cancer survivors more likely to have preterm birth, cesarean delivery

March 23, 2017
Adult survivors of adolescent and young adult cancers were more likely to experience preterm birth, low birth weight and cesarean delivery compared…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to…

FDA News

FDA updates safety alert on breast implant–associated anaplastic large cell lymphoma, reports 9 deaths

March 22, 2017
The FDA issued a safety alert update on breast implant-associated anaplastic large cell lymphoma, recommending clinicians provide routine care and…

In the Journals

Cancer surveillance guidelines lack specificity, consistency

March 20, 2017
Recommendations for surveillance after cancer treatment in survivors across guidelines are often nonspecific and inconsistent; therefore…

Meeting NewsPerspective

Exercise helps decrease CV risk in women after breast cancer

March 20, 2017
WASHINGTON — Regular exercise was associated with reductions in CV risk among women treated for breast cancer, according to a new report…

Addition of abemaciclib to fulvestrant improves PFS in advanced breast cancer

March 20, 2017
The addition of abemaciclib to fulvestrant significantly extended PFS among certain women with advanced breast cancer, according to the drug’s…

Leading cancer organizations: Trump’s proposed NIH budget cuts will threaten research, patient care

March 17, 2017
Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s…

More Headlines »
Advertisement
Advertisement